![]() ![]() Weber leads the Alzheimer's Association Business Consortium (AABC), which advances innovation in small- and medium-size biotechnology, diagnostics, medical device and contract organizations through pre-competitive collaborations, knowledge sharing and visibility. He also oversees the Global Biomarker Standardization Consortium (GBSC), an initiative that unites key researchers and clinicians with industry, regulatory and government leaders to achieve consensus on the best ways to standardize and validate biomarker tests for use in clinical practices worldwide. He manages the Alzheimer's Association Research Roundtable, a platform that enables international scientific, industry and government leaders to overcome shared obstacles in Alzheimer's science and drug development. Weber directs Association initiatives that convene leaders from across the field to develop, expand and increase the success rate of Alzheimer's diagnostic tools and drugs to treat and prevent the disease. Weber is responsible for communicating the global research landscape of Alzheimer's and dementia, including the breadth and reach of the Association's research programs, and the critical need for increased research funding from the public and private sectors.ĭr. With over 20 years of clinical research experience, Dr. ![]() Christopher Weber, Ph.D., director, Global Science Initiatives, oversees efforts to advance the scientific agenda of the Alzheimer's Association, the world’s largest nonprofit funder of Alzheimer's research, with $320 million currently invested in more than 1,000 projects in 54 countries.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |